Literature DB >> 17846239

Metastatic iridociliary adenocarcinoma in a labrador retriever.

M K Zarfoss1, R R Dubielzig.   

Abstract

An enucleated left eye from a 15-year-old female spayed Labrador Retriever was received by the Comparative Ocular Pathology Laboratory of Wisconsin (COPLOW) for histopathologic evaluation. Routine histologic preparation included staining with hematoxylin and eosin, and with alcian blue periodic acid-Schiff (PAS). At necropsy 9 months later, all grossly abnormal tissues (ipsilateral orbit and lung) were submitted to the COPLOW for histopathologic evaluation. Histopathologic evaluation of the globe revealed extensive invasion of the uvea and sclera by a pleomorphic cell population that formed disorganized cords and exhibited PAS-positive basement membrane material. Necropsy revealed a morphologically similar tumor in the ipsilateral orbit and lung. On immunohistochemical examination, the intraocular tumor stained diffusely immunopositive for vimentin, S-100, and neuron-specific enolase and multifocally, sparsely immunopositive for cytokeratin AE1/AE3. The orbital and thoracic tumors stained positively for vimentin but negatively for cytokeratin AE1/AE3. There are few reports of canine metastatic iridociliary adenocarcinoma in the literature; this is the first with immunohistochemical analysis.

Entities:  

Mesh:

Year:  2007        PMID: 17846239     DOI: 10.1354/vp.44-5-672

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  2 in total

1.  Iridociliary adenoma in a greater sulfur-crested cockatoo (Cacatua galerita galerita).

Authors:  Sara Gardhouse; Chantale L Pinard; Trinita Barboza; Britta Knight; Omar A Zaheer; Leonardo Susta; Hugues Beaufrère
Journal:  Can Vet J       Date:  2021-03       Impact factor: 1.008

2.  Iridociliary adenocarcinoma with oncocytic change in a dog.

Authors:  Mitsuteru Okawauchi; Masaya Tsuboi; Kazumi Nibe; Eiji Nagamine; Hideaki Iwane; Kazuyuki Uchida
Journal:  J Vet Med Sci       Date:  2016-01-29       Impact factor: 1.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.